Schmiegelow K - Search Results

1

Remission, treatment failure, and relapse in pediatric ALL: an international consensus of the Ponte-di-Legno Consortium.

Buchmann S, Schrappe M, Baruchel A, Biondi A, Borowitz M, Campbell M, Cario G, Cazzaniga G, Escherich G, Harrison CJ, Heyman M, Hunger SP, Kiss C, Liu HC, Locatelli F, Loh ML, Manabe A, Mann G, Pieters R, Pui CH, Rives S, Schmiegelow K, Silverman LB, Stary J, Vora A, Brown P. Buchmann S, et al. Among authors: schmiegelow k. Blood. 2022 Mar 24;139(12):1785-1793. doi: 10.1182/blood.2021012328. Blood. 2022. PMID: 34192312 Free PMC article.

2

Inhibition of granulocyte-macrophage colony-stimulating factor prevents dissemination and induces remission of juvenile myelomonocytic leukemia in engrafted immunodeficient mice.

Iversen PO, Lewis ID, Turczynowicz S, Hasle H, Niemeyer C, Schmiegelow K, Bastiras S, Biondi A, Hughes TP, Lopez AF. Iversen PO, et al. Among authors: schmiegelow k. Blood. 1997 Dec 15;90(12):4910-7. Blood. 1997. PMID: 9389708 Free article.

3

Relation between age, immunophenotype and in vitro drug resistance in 395 children with acute lymphoblastic leukemia--implications for treatment of infants.

Pieters R, den Boer ML, Durian M, Janka G, Schmiegelow K, Kaspers GJ, van Wering ER, Veerman AJ. Pieters R, et al. Among authors: schmiegelow k. Leukemia. 1998 Sep;12(9):1344-8. doi: 10.1038/sj.leu.2401129. Leukemia. 1998. PMID: 9737681

4

TEL/AML1 gene fusion is related to in vitro drug sensitivity for L-asparaginase in childhood acute lymphoblastic leukemia.

Ramakers-van Woerden NL, Pieters R, Loonen AH, Hubeek I, van Drunen E, Beverloo HB, Slater RM, Harbott J, Seyfarth J, van Wering ER, Hählen K, Schmiegelow K, Janka-Schaub GE, Veerman AJ. Ramakers-van Woerden NL, et al. Among authors: schmiegelow k. Blood. 2000 Aug 1;96(3):1094-9. Blood. 2000. PMID: 10910927 Free article.

5

Post-induction residual leukemia in childhood acute lymphoblastic leukemia quantified by PCR correlates with in vitro prednisolone resistance.

Schmiegelow K, Nyvold C, Seyfarth J, Pieters R, Rottier MM, Knabe N, Ryder LP, Madsen HO, Svejgaard A, Kaspers GJ. Schmiegelow K, et al. Leukemia. 2001 Jul;15(7):1066-71. doi: 10.1038/sj.leu.2402144. Leukemia. 2001. PMID: 11455975

6

Precise quantification of minimal residual disease at day 29 allows identification of children with acute lymphoblastic leukemia and an excellent outcome.

Nyvold C, Madsen HO, Ryder LP, Seyfarth J, Svejgaard A, Clausen N, Wesenberg F, Jonsson OG, Forestier E, Schmiegelow K; Nordic Society for Pediatric Hematology and Oncology. Nyvold C, et al. Among authors: schmiegelow k. Blood. 2002 Feb 15;99(4):1253-8. doi: 10.1182/blood.v99.4.1253. Blood. 2002. PMID: 11830473 Free article.

7

Increased frequency of mannose-binding lectin insufficiency among children with acute lymphoblastic leukemia.

Schmiegelow K, Garred P, Lausen B, Andreassen B, Petersen BL, Madsen HO. Schmiegelow K, et al. Blood. 2002 Nov 15;100(10):3757-60. doi: 10.1182/blood-2002-06-1627. Epub 2002 Jul 5. Blood. 2002. PMID: 12393405 Free article.

8

The seventh international childhood acute lymphoblastic leukemia workshop report: Palermo, Italy, January 29--30, 2005.

Aricó M, Baruchel A, Bertrand Y, Biondi A, Conter V, Eden T, Gadner H, Gaynon P, Horibe K, Hunger SP, Janka-Schaub G, Masera G, Nachman J, Pieters R, Schrappe M, Schmiegelow K, Valsecchi MG, Pui CH. Aricó M, et al. Among authors: schmiegelow k. Leukemia. 2005 Jul;19(7):1145-52. doi: 10.1038/sj.leu.2403783. Leukemia. 2005. PMID: 15902295

9

High-dose compared with intermediate-dose methotrexate in children with a first relapse of acute lymphoblastic leukemia.

von Stackelberg A, Hartmann R, Bührer C, Fengler R, Janka-Schaub G, Reiter A, Mann G, Schmiegelow K, Ratei R, Klingebiel T, Ritter J, Henze G; ALL-REZ BFM Study Group. von Stackelberg A, et al. Among authors: schmiegelow k. Blood. 2008 Mar 1;111(5):2573-80. doi: 10.1182/blood-2007-07-102525. Epub 2007 Dec 18. Blood. 2008. PMID: 18089849 Free article. Clinical Trial.

10

T-cell receptor Vbeta CDR3 oligoclonality frequently occurs in childhood refractory cytopenia (MDS-RC) and severe aplastic anemia.

de Vries AC, Langerak AW, Verhaaf B, Niemeyer CM, Stary J, Schmiegelow K, van Wering ER, Zwaan CM, Beishuizen A, Pieters R, van den Heuvel-Eibrink MM. de Vries AC, et al. Among authors: schmiegelow k. Leukemia. 2008 Jun;22(6):1170-4. doi: 10.1038/leu.2008.23. Epub 2008 Mar 6. Leukemia. 2008. PMID: 18323803

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

537 results

Search Page